Skip to main content
Duke University Libraries
Search 
  •   DukeSpace
  • Duke Scholarly Works
  • Search
  •   DukeSpace
  • Duke Scholarly Works
  • Search
    • Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-3 of 3

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Economics of new oncology drug development. 

    DiMasi, Joseph A; Grabowski, Henry G (J Clin Oncol, 2007-01-10)
    PURPOSE: Review existing studies and provide new results on the development, regulatory, and market aspects of new oncology drug development. METHODS: We utilized data from the US Food and Drug Administration (FDA), company ...
    Thumbnail

    Should the patent system for new medicines be abolished? 

    DiMasi, Joseph A; Grabowski, Henry G (Clin Pharmacol Ther, 2007-11)
    Thumbnail

    The cost of biopharmaceutical R&D: Is biotech different? 

    DiMasi, Joseph A; Grabowski, Henry G (Managerial and Decision Economics, 2007-06-01)
    The costs of developing the types of new drugs that have been pursued by traditional pharmaceutical firms have been estimated in a number of studies. However, similar analyses have not been published on the costs of developing ...
     

     

    Browse

    All of DukeSpaceCommunities & CollectionsAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit DateThis CommunityAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit Date

    My Account

    LoginRegister

    Discover

    Author
    DiMasi, Joseph A (3)
    Grabowski, Henry G (3)Date Issued
    2007 (3)
    TypeJournal article (3)SubjectDrug Costs (2)Drug Industry (2)Humans (2)Antineoplastic Agents (1)Biomedical Research (1)Commerce (1)Cost-Benefit Analysis (1)Drug Approval (1)Drug Design (1)Economics, Pharmaceutical (1)... View MoreAffiliation of Duke Author(s)
    Duke (3)
    Economics (3)
    Trinity College of Arts & Sciences (3)